Haemodynamic effects of pindolol in hypertensive patients
- PMID: 268933
- DOI: 10.1111/j.0954-6820.1977.tb18030.x
Haemodynamic effects of pindolol in hypertensive patients
Abstract
Five men and five women, mean age 48 years, with hypertension in stages I or II of the WHO classification, were given preoral treatment with pindolol. The pindolol treatment lead a significant decrease in the systolic and diastolic blood pressure, at rest and during work both after 2 months and after 16 months treatment. Three mechanisms seem to be involved in the antihypertensive effect of pindolol: 1) a negative chronotropic effect on the heart, 2) a decrease in peripheral vascular resistance and 3) an increase in venous capacitance affecting the venous return. Comparison of the results after 2 and after 16 months of treatment suggests that a decrease in cardiac output is an early mechanism in the lowering of the blood pressure, while a decrease in vascular resistance seems to be more important after long-term treatment with pindolol.
Similar articles
-
Hemodynamic effect of pindolol in essential hypertension with special reference to the resistance and capacitance vessels of the forearm.Acta Med Scand. 1976;199(4):251-5. doi: 10.1111/j.0954-6820.1976.tb06728.x. Acta Med Scand. 1976. PMID: 1266662
-
Experience with pindolol, a betareceptor blocker, in the treatment of hypertension.Am J Med. 1976 May 31;60(6):872-6. doi: 10.1016/0002-9343(76)90907-4. Am J Med. 1976. PMID: 14501
-
Hemodynamic effect of long--term treatment with pindolol in essential hypertension with special reference to the resistance and capacitance vessels of the forearm.Acta Med Scand. 1977;202(6):517-21. doi: 10.1111/j.0954-6820.1977.tb16874.x. Acta Med Scand. 1977. PMID: 339674 Clinical Trial.
-
Clinical pharmacology of pindolol.Am Heart J. 1982 Aug;104(2 Pt 2):346-56. doi: 10.1016/0002-8703(82)90125-9. Am Heart J. 1982. PMID: 6125094 Review.
-
Reversibility of structural changes in the resistance vessels in hypertension: a review of studies with pindolol.Br J Clin Pharmacol. 1987;24 Suppl 1(Suppl 1):51S-54S. doi: 10.1111/j.1365-2125.1987.tb03269.x. Br J Clin Pharmacol. 1987. PMID: 3326635 Free PMC article. Review.
Cited by
-
Long-term hemodynamic effects of penbutolol at rest and during exercise in essential hypertension.Eur J Clin Pharmacol. 1979 Sep;16(3):149-53. doi: 10.1007/BF00562054. Eur J Clin Pharmacol. 1979. PMID: 499314 No abstract available.
-
Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combined alpha- and beta-adrenoreceptor blockade by labetalol.Br Heart J. 1979 Feb;41(2):192-8. doi: 10.1136/hrt.41.2.192. Br Heart J. 1979. PMID: 106867 Free PMC article. No abstract available.
-
Adaptation of hypertensives to treatment with cardioselective and non-selective beta-blockers. Absence of correlation between bradycardia and blood pressure control, and reduction in slope of the QT/RR relation.Br Heart J. 1980 Nov;44(5):473-87. doi: 10.1136/hrt.44.5.473. Br Heart J. 1980. PMID: 6108122 Free PMC article. Clinical Trial.
-
Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.Drugs. 1984;28 Suppl 2:35-50. doi: 10.2165/00003495-198400282-00004. Drugs. 1984. PMID: 6151890 Review.
-
Effect of celiprolol on large and small arteries of the forearm circulation in hypertensive patients.Cardiovasc Drugs Ther. 1990 Jun;4(3):745-9. doi: 10.1007/BF01856564. Cardiovasc Drugs Ther. 1990. PMID: 2150174 Clinical Trial.